Protocol for a randomised, double-blind trial of a chronotherapeutic mobile health (mHealth) behaviour change intervention to optimise light exposure among older adults aged ≥ 60 years in Singapore (LightSPAN)

Suboptimal light exposure among older adults can exacerbate circadian disruption, sleep disturbances, mood disorders, cognitive decline, and frailty. In urbanised environments like Singapore, older adults are particularly vulnerable due to lifestyle and built environment constraints. The LightSPAN study evaluates a chronotherapeutic mobile health (mHealth) behaviour change intervention, delivered via the LightUP app, designed to optimise light exposure patterns and support healthy ageing. The trial is a community-based, double-blind, parallel-group randomised controlled trial involving approximately 90 community-dwelling older adults (≥ 60 years) recruited through Active Ageing Centres in Singapore. Participants will be randomised using a secure web-based system with stratification by age, sex and recruitment site to receive either the active LightUP app with behaviour change features (goal setting, self-monitoring, personalised feedback) or a placebo version without these features. The primary outcome is daily time above 250 lx melanopic equivalent daylight illuminance (melanopic EDI) during daytime, measured with the ActLumus light logger across baseline, intervention and follow-up periods. Secondary outcomes include sleep parameters and circadian rest-activity rhythms, sleep quality, mood, cognition, frailty status, physical activity, body composition and vitamin D levels. The usability and acceptability of the LightUP app and wearable devices will also be assessed. Analyses will follow the intention-to-treat principle, supplemented by per-protocol analyses. Generalised linear mixed models will be used for repeated measures, with multiple imputation for missing data and exploratory Bayesian analyses. All analyses will be pre-registered on the Open Science Framework and de-identified datasets and code will be openly shared under a CC-BY license. Despite its central role in circadian regulation, light exposure has rarely been targeted in behavioural preventive interventions for older adults. This study evaluates a novel mHealth-enabled approach that empowers older adults to optimise their light exposure, extending the scope of non-pharmacological strategies for preventive medicine and health promotion. This study was retrospectively registered at the ISRCTN – The UK’s Clinical Study Registry on 05 September 2025 (ID: ISRCTN12391932, https://doi.org/10.1186/ISRCTN12391932).

Authors

Institutions

Publication Details

Journal
BMC Geriatrics
Published
2026-02-25
DOI
https://doi.org/10.1186/s12877-026-07105-6
Primary Topic
Circadian rhythm and melatonin
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Protocol for a randomised, double-blind trial of a chronotherapeutic mobile health (mHealth) behaviour change intervention to optimise light exposure among older adults aged ≥ 60 years in Singapore (LightSPAN)

Resshaya Roobini Murukesu, Johannes Zauner, Zahrah Alwi Alkaff, Manuel Spitschan et al.
BMC Geriatrics
Circadian rhythm and melatonin
article

Protocol for a randomised, double-blind trial of a chronotherapeutic mobile health (mHealth) behaviour change intervention to optimise light exposure among older adults aged ≥ 60 years in Singapore (LightSPAN)

Resshaya Roobini Murukesu, Johannes Zauner, Zahrah Alwi Alkaff, Manuel Spitschan, Denz Del Villar
article en

Abstract

Suboptimal light exposure among older adults can exacerbate circadian disruption, sleep disturbances, mood disorders, cognitive decline, and frailty. In urbanised environments like Singapore, older adults are particularly vulnerable due to lifestyle and built environment constraints. The LightSPAN study evaluates a chronotherapeutic mobile health (mHealth) behaviour change intervention, delivered via the LightUP app, designed to optimise light exposure patterns and support healthy ageing. The trial is a community-based, double-blind, parallel-group randomised controlled trial involving approximately 90 community-dwelling older adults (≥ 60 years) recruited through Active Ageing Centres in Singapore. Participants will be randomised using a secure web-based system with stratification by age, sex and recruitment site to receive either the active LightUP app with behaviour change features (goal setting, self-monitoring, personalised feedback) or a placebo version without these features. The primary outcome is daily time above 250 lx melanopic equivalent daylight illuminance (melanopic EDI) during daytime, measured with the ActLumus light logger across baseline, intervention and follow-up periods. Secondary outcomes include sleep parameters and circadian rest-activity rhythms, sleep quality, mood, cognition, frailty status, physical activity, body composition and vitamin D levels. The usability and acceptability of the LightUP app and wearable devices will also be assessed. Analyses will follow the intention-to-treat principle, supplemented by per-protocol analyses. Generalised linear mixed models will be used for repeated measures, with multiple imputation for missing data and exploratory Bayesian analyses. All analyses will be pre-registered on the Open Science Framework and de-identified datasets and code will be openly shared under a CC-BY license. Despite its central role in circadian regulation, light exposure has rarely been targeted in behavioural preventive interventions for older adults. This study evaluates a novel mHealth-enabled approach that empowers older adults to optimise their light exposure, extending the scope of non-pharmacological strategies for preventive medicine and health promotion. This study was retrospectively registered at the ISRCTN – The UK’s Clinical Study Registry on 05 September 2025 (ID: ISRCTN12391932, https://doi.org/10.1186/ISRCTN12391932).

BMC Geriatrics
Max Planck Institute for Biological Cybernetics (DE), CREATe Centre (GB), Technical University of Munich (DE)
Sustainable cities and communities
Openalex Percentile: Top 39%
Circadian rhythm and melatonin
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.